HSA and FSA for TRT: What's Covered, What It Costs, and How to Pay Less

Can You Use an HSA or FSA to Pay for TRT?

Yes. Testosterone replacement therapy prescribed by a licensed physician qualifies as an eligible medical expense under IRS Publication 502, which governs both Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). That means the medication itself, required blood panels, and physician fees all count. The only hard rule: a prescription is required. Over-the-counter testosterone boosters do not qualify.

The IRS defines eligible expenses as costs paid "for the diagnosis, cure, mitigation, treatment, or prevention of disease." Clinical hypogonadism (ICD-10 code E29.1) is a recognized disease state, so a properly documented TRT prescription sits squarely inside that definition. The FDA maintains the current label for testosterone products at accessdata.fda.gov, and the prescribing diagnosis is what ties those products to HSA/FSA eligibility.

Practically speaking, most HSA and FSA administrators process testosterone prescriptions without any extra documentation. If your account administrator does flag a claim, submitting your physician's prescription and the Explanation of Benefits (or pharmacy receipt showing the drug name) resolves it in nearly all cases.

One important caveat: FSA funds expire at year-end for most plans (with a $640 rollover cap in 2024), while HSA funds roll over indefinitely and grow tax-free. If you are managing TRT costs long-term, maximizing an HSA through a high-deductible health plan almost always produces better tax savings than relying on an FSA alone.

How Much Does TRT Cost Per Month?

Monthly TRT costs depend heavily on which formulation you use, whether you have insurance, and whether you go through a direct-care clinic or a traditional practice. Generic testosterone cypionate injections, the most prescribed form in the United States, cost $30 to $80 per month at retail pharmacies. Topical gels (AndroGel, Testim) run $200 to $500 per month brand-name, though generic testosterone gel has dropped to $60 to $150 per month. Pellet implants are placed every three to six months and cost $300 to $800 per insertion procedure.

Online TRT clinics bundle medication, consultations, and sometimes labs into a monthly subscription. Prices published by major telehealth providers in mid-2025 start around $99 per month for injectable protocols and rise to $200 to $300 per month for more comprehensive monitoring packages. These prices typically exclude the initial lab draw, which runs $100 to $250 without insurance. PubMed data on hypogonadism treatment adherence shows that cost barriers are one of the top three reasons men discontinue therapy within the first year, which is why knowing these numbers up front matters.

A realistic all-in monthly budget looks like this:

• Testosterone cypionate injection (self-administered): $40 to $80
• Quarterly lab panel (amortized monthly): $25 to $85
• Physician/provider fee (amortized monthly): $30 to $100
• Supplies (syringes, alcohol swabs): $5 to $15
• Total range: $100 to $280 per month for injectable TRT

Topical and pellet formulations push that number higher. Compounded testosterone (produced at a 503A or 503B pharmacy) often costs 30 to 60 percent less than brand-name products and is fully HSA/FSA eligible, though insurance almost never covers it.

What Does Insurance Actually Cover for TRT?

Insurance coverage for TRT exists, but it is conditional. Most commercial plans will cover FDA-approved testosterone formulations when the treating physician documents clinical hypogonadism: two fasting morning total testosterone readings below 300 ng/dL (the threshold cited in the American Urological Association's 2018 Testosterone Deficiency Guideline) combined with signs and symptoms consistent with the diagnosis.

The Endocrine Society's 2018 Clinical Practice Guideline states: "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone concentrations." [1] That language matters because insurers use it as a coverage trigger. A lab value alone without documented symptoms, or symptoms alone without two abnormal labs, often results in a denial.

Specific coverage limitations to know:

Compounded testosterone is almost universally excluded. Commercial insurers classify compounded drugs as non-covered because they lack FDA approval as finished drug products. Paying cash and using HSA/FSA funds is the standard workaround.

Brand-name gels face high prior-authorization hurdles. Plans that do cover testosterone typically require step therapy, meaning you must try and fail on generic testosterone cypionate before the plan will approve AndroGel or Natesto.

Anastrozole and hCG as adjunct TRT medications are sometimes prescribed alongside testosterone to manage estrogen or preserve fertility. Coverage for these is inconsistent. Both are HSA/FSA eligible when prescribed.

Monitoring labs (total testosterone, free testosterone, hematocrit, PSA, LH, FSH) may or may not be covered as "medically necessary," depending on your plan's lab benefit. CDC data on hypogonadism prevalence shows roughly 2.4 million American men aged 40 to 79 have symptomatic androgen deficiency, which has pushed many major insurers to develop explicit TRT coverage policies rather than deciding case by case.

Does Medicare Cover TRT?

Medicare covers FDA-approved testosterone medications under Part D (prescription drug coverage) when they are prescribed for a documented medical condition, specifically clinical hypogonadism. Age-related testosterone decline alone, sometimes called late-onset hypogonadism, occupies a gray zone. The FDA has required testosterone product labeling to specify that these drugs are "approved only for men who have low testosterone due to a medical condition," not solely due to aging. [2]

Medicare Part B does not cover self-administered testosterone injections or gels in most circumstances. However, if testosterone is administered in a physician's office (less common for TRT), Part B may apply. The practical takeaway: most men on Medicare who are self-injecting or using topical testosterone will route their prescription through Part D. A $0-deductible or low-deductible Part D plan can reduce out-of-pocket testosterone costs to $0 to $50 per month for generics.

Medicare beneficiaries cannot contribute to an HSA once enrolled in any part of Medicare. However, they can spend existing HSA funds on Medicare premiums, Part D co-pays, and testosterone-related medical expenses. This is a detail many men miss when transitioning from employer coverage to Medicare.

How Much Does Online TRT Cost vs. In-Person Clinics?

Online TRT clinics have compressed costs significantly over the past five years. The model works because telehealth providers skip the brick-and-mortar overhead of traditional men's health clinics and route prescriptions directly to mail-order or local pharmacies. A 2023 analysis in the Journal of Urology found that telehealth substantially increased TRT access among men in rural areas, where in-person endocrinology or urology appointments can involve months-long waits.

Typical online TRT pricing structures fall into two categories:

Subscription model: A flat monthly fee covering async or synchronous provider visits, prescription management, and sometimes medication. Prices run $99 to $200 per month. Labs are usually ordered separately through a partner lab (LabCorp, Quest) and billed to insurance or paid out-of-pocket at $100 to $200 per panel.

Medication-only model: The clinic charges only for physician visits and the prescription. You fill the testosterone at a local or mail-order pharmacy and pay separately. This model can be cheaper if you have Part D or commercial insurance covering the medication.

In-person men's health clinics (brick-and-mortar) typically charge $150 to $350 per month for similar injectable protocols, with higher fees in major metro areas. The clinical outcomes data comparing online to in-person TRT are limited, but a 2022 study in Urology Practice found no statistically significant difference in testosterone level normalization rates between telehealth-initiated and in-office-initiated TRT at 12 months.

All of these costs, whether from an online clinic or a traditional urology practice, are HSA and FSA eligible when a valid prescription is attached to the expense.

Which TRT Formulations Give You the Best Cost-Per-Outcome Ratio?

Not all testosterone formulations cost the same, and the differences are large enough to affect whether HSA/FSA funds last the year. The table below organizes formulations by monthly cost, administration frequency, and key clinical considerations. This framework is original to HealthRX and is intended to help patients have a data-grounded conversation with their prescriber.

Testosterone Cypionate (Intramuscular or Subcutaneous Injection) Cost: $30 to $80/month (generic). Dosing: typically 100 to 200 mg/week or every two weeks. Bioavailability is high and serum levels are predictable. The Testosterone Trials (TTrials), a consortium of seven placebo-controlled studies in 788 men, used injectable testosterone as one of the primary delivery methods and showed significant improvements in sexual function and bone density. The generic cost makes this the most HSA/FSA-efficient option for most men.

Testosterone Enanthate (Intramuscular) Cost: $40 to $90/month (generic). Nearly identical pharmacokinetics to cypionate. Slightly longer half-life (4.5 days vs. 8 days for cypionate) is clinically negligible at weekly dosing intervals.

Testosterone Gel (Topical, 1% or 1.62%) Cost: $60 to $150/month (generic); $250 to $500/month (AndroGel brand). Daily application. Steady serum levels. Transfer risk to partners and children requires careful application and handwashing. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, used a 1.62% testosterone gel and found no statistically significant increase in major adverse cardiovascular events compared to placebo over a median follow-up of 33 months, providing important safety data.

Testosterone Pellets (Subcutaneous Implant) Cost: $300 to $800 per insertion, every 3 to 6 months ($50 to $270/month amortized). Inserted in-office under local anesthesia. Stable levels, no daily dosing. Insurance rarely covers the procedure; HSA funds work well here because the lump-sum cost fits the HSA's rollover advantage.

Compounded Testosterone (Cream, Cypionate, Enanthate) Cost: $50 to $120/month from a 503A compounding pharmacy. Not FDA-approved as a finished product but may be prescribed when a commercial product is clinically inappropriate. Fully HSA/FSA eligible. Insurance coverage: almost never.

Nasal Testosterone (Natesto) Cost: $300 to $500/month (brand only, no generic). Three-times-daily dosing. Preferred in men who want to preserve fertility because its short half-life minimally suppresses LH/FSH. High cost limits HSA/FSA efficiency unless the fertility indication is clinically necessary.

The framework question to bring to your provider: "Given my insurance situation and HSA balance, which formulation gives me reliable serum levels at the lowest total annual cost?" For most uninsured or underinsured men, weekly subcutaneous testosterone cypionate injections answer that question.

How to Maximize HSA and FSA Savings on TRT

The IRS contribution limit for HSAs in 2025 is $4,300 for individuals and $8,550 for families, with a $1,000 catch-up contribution allowed for those 55 and older. [3] A man spending $2,400 per year on TRT (a modest estimate for injectable therapy with quarterly labs) who funds his HSA with pre-tax dollars effectively pays for that care at his marginal tax rate discount. At a 22% federal bracket, that is a $528 annual savings on TRT alone.

Practical steps:

1. Get the diagnosis documented. Your provider should note ICD-10 E29.1 (testicular hypofunction) or E29.9 on the prescription and visit notes. This protects you if your HSA/FSA administrator audits the claim.

2. Use your HSA debit card directly at the pharmacy. This avoids reimbursement paperwork and creates an automatic audit trail.

3. Batch your lab draws. Instead of labs every 6 weeks, ask your provider whether quarterly monitoring (standard per most guidelines after the first stabilization period) is appropriate. Cutting from 8 panels per year to 4 saves $400 to $800 annually.

4. Compare GoodRx to your HSA rate. GoodRx discounts on testosterone cypionate sometimes beat the negotiated HSA pharmacy rate. You cannot pay with your HSA card at GoodRx prices (it requires paying cash), but you can pay cash and then submit for HSA reimbursement using the pharmacy receipt. IRS Publication 502 allows reimbursement of out-of-pocket prescription costs even when no insurance is involved.

5. Time FSA elections to your TRT calendar. If you know you are starting pellet therapy in January, elect enough FSA funds to cover the insertion procedure (which may run $500 to $800) at your first 2025 contribution.

The Endocrine Society's guideline also notes that monitoring should include hematocrit at baseline, 3 to 6 months, and then annually, plus PSA in men over 40 at baseline and at 3 to 6 months. [1] Building those costs into your annual HSA budget prevents surprise out-of-pocket bills.

TRT and Insurance Denials: What to Do

Insurance denials for TRT are common and often reversible. The most frequent denial reasons:

"Not medically necessary" usually means the insurer did not receive both qualifying lab values or did not see documented symptoms. The fix: ask your provider to submit a Letter of Medical Necessity citing the two testosterone levels, the symptom inventory (fatigue, decreased libido, loss of muscle mass), and the relevant guideline language from the Endocrine Society or AUA.

"Non-covered drug" for compounded testosterone is almost never overturned on appeal because it reflects a plan exclusion, not a medical decision. Paying with HSA/FSA funds is the correct path here.

"Step therapy not completed" applies to brand-name gels and patches when the plan requires a generic trial first. Completing the step (or having your physician document a clinical reason the step is contraindicated) resolves this.

A 2020 analysis in JAMA Internal Medicine found that patients who filed formal appeals overturned insurance denials at a rate of 39 to 59% depending on the plan type. Filing the appeal is worth the hour of paperwork.

If an appeal fails, the remaining options are: (1) pay cash and use HSA/FSA funds, (2) ask your pharmacy about manufacturer savings cards (available for brand-name products like Jatenzo or Natesto), or (3) switch to the generic injectable formulation that most plans cover when properly documented.